<DOC>
	<DOC>NCT01245387</DOC>
	<brief_summary>Long-term observational study to assess the safety, efficacy and quality of life of patients with neovascular age-related macular degeneration (AMD) under Macugen treatment.</brief_summary>
	<brief_title>Observational Study Of The Long-Term Effect Of Macugen In Patients With Wet Age-Related Macular Degeneration</brief_title>
	<detailed_description>Ophthalmologists who are experienced in doing intravitreal injections in Germany</detailed_description>
	<mesh_term>Macular Degeneration</mesh_term>
	<mesh_term>Wet Macular Degeneration</mesh_term>
	<criteria>patients with neovascular agerelated macular degeneration</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2011</verification_date>
	<keyword>prospective</keyword>
	<keyword>observational</keyword>
	<keyword>Phase 4</keyword>
	<keyword>non-interventional</keyword>
	<keyword>open-label</keyword>
</DOC>